Literature DB >> 9881907

Sequence analysis of thyroid transcription factor-1 gene reveals absence of mutations in patients with thyroid dysgenesis but presence of polymorphisms in the 5' flanking region and intron.

A Hishinuma1, T Kuribayashi, Y Kanno, K Onigata, K Nagashima, T Ieiri.   

Abstract

Congenital hypothyroidism is caused by several mechanisms. The most common cause worldwide is iodine deficiency, but in iodine-sufficient regions thyroid dysgenesis is the most common cause of congenital hypothyroidism. In the present study we analyzed the thyroid transcription factor-1 (TTF-1) gene in patients with congenital hypothyroidism due to thyroid dysgenesis: three patients with athyrosis, five with ectopy, and one with hypoplasia. Genomic DNA was isolated from peripheral leukocytes, and the TTF-1 gene, including a 5' flanking region, two exons and one intron was amplified by polymerase chain reaction (PCR) with 4 pairs of primers. The PCR products were directly sequenced by the Dye Terminator Cycle Sequencing method. We could not find any mutations specific for the thyroid dysgenesis in the 5' flanking region, two exons and one intron in the TTF-1 gene, but two heterozygous nucleotide substitutions were detected in the intron: a G to A transition at nucleotide 469 (G469A) and a C to A transversion at nucleotide 866 (C866A). The same nucleotide changes were detected in some normal subjects. Allelic frequencies of the polymorphisms G469A and C866A were 23% and 10%, respectively. Another normal polymorphism in the 5' flanking region was a G to T transversion at nucleotide -845 from the transcription start site (G-845T). The allelic frequency of the polymorphism G-845T was 28%. We also found 12 polymorphisms in the 5' flanking region, two in the intron and one in the 3' untranslated region. These polymorphisms were detected in 100% chromosomes. These results suggest that congenital hypothyroidism associated with thyroid dysgenesis is unlikely to be caused by mutations in the TTF-1 gene in which, however, were detected normal polymorphisms in the 5' flanking region, intron and 3' untranslated region.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9881907     DOI: 10.1507/endocrj.45.563

Source DB:  PubMed          Journal:  Endocr J        ISSN: 0918-8959            Impact factor:   2.349


  3 in total

1.  Comprehensive genotyping and clinical characterisation reveal 27 novel NKX2-1 mutations and expand the phenotypic spectrum.

Authors:  Anne Thorwarth; Sarah Schnittert-Hübener; Pamela Schrumpf; Ines Müller; Sabine Jyrch; Christof Dame; Heike Biebermann; Gunnar Kleinau; Juri Katchanov; Markus Schuelke; Grit Ebert; Anne Steininger; Carsten Bönnemann; Knut Brockmann; Hans-Jürgen Christen; Patricia Crock; Francis deZegher; Matthias Griese; Jacqueline Hewitt; Sten Ivarsson; Christoph Hübner; Klaus Kapelari; Barbara Plecko; Dietz Rating; Iva Stoeva; Hans-Hilger Ropers; Annette Grüters; Reinhard Ullmann; Heiko Krude
Journal:  J Med Genet       Date:  2014-04-08       Impact factor: 6.318

2.  Choreoathetosis, hypothyroidism, and pulmonary alterations due to human NKX2-1 haploinsufficiency.

Authors:  Heiko Krude; Barbara Schütz; Heike Biebermann; Arpad von Moers; Dirk Schnabel; Heidi Neitzel; Holger Tönnies; Dagmar Weise; Antony Lafferty; Siegfried Schwarz; Mario DeFelice; Andreas von Deimling; Frank van Landeghem; Roberto DiLauro; Annette Grüters
Journal:  J Clin Invest       Date:  2002-02       Impact factor: 14.808

3.  Gene Variants in NKX2-1 Do Not Represent a Major Etiological Factor of Primary Congenital Hypothyroidism in Mexican Population.

Authors:  Ariadna González-Del Angel; Liliana Fernández-Hernández; Iraís Sánchez-Verdiguel; Aidy González-Núñez; Víctor Martínez-Cruz; Carmen Sánchez; Rosario Moreno-Rojas; Miguel Angel Alcántara-Ortigoza
Journal:  J Pediatr Genet       Date:  2019-01-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.